# Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients

> **NCT06991712** · PHASE2 · RECRUITING · sponsor: **Christopher Kai Shun Leung** · enrollment: 138 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside
- **DIETARY_SUPPLEMENT:** Nicotinamide
- **DIETARY_SUPPLEMENT:** Nicotinamide Mononucleotide
- **DIETARY_SUPPLEMENT:** Nicotinic Acid
- **OTHER:** Placebo (Corn Starch)
- **OTHER:** Placebo (Corn Starch)

## Key facts

- **NCT ID:** NCT06991712
- **Lead sponsor:** Christopher Kai Shun Leung
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-19
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991712, "Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06991712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*